Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 50.15
+0.37 (0.74%)
Nov 10, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 27.34 billion as of November 9, 2026. It is the 4,611th most valuable company in the world and the 227th biggest in Hong Kong. Its market cap has decreased by 17.66% in one year.
Market Cap
27.34B
Enterprise Value
30.80B
Revenue
8.58B
Global Rank
Country Rank
#227 Hong Kong
PE Ratio
27.50
ChartMarket Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 27.34B, an increase of 2.57%. That is a compound annual growth rate of 0.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 27.34B | -11.81% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 69.28B |
| RemeGen | 54.09B |
| 3SBio | 37.83B |
| Biocytogen Pharmaceuticals (Beijing) | 35.57B |
| Shanghai Junshi Biosciences | 31.81B |
| InnoCare Pharma | 25.69B |
| Zai Lab | 24.80B |
| InSilico Medicine Cayman TopCo | 21.57B |